Skip to main content
. 2021 Apr 30;53(2):300–307. doi: 10.3947/ic.2020.0149

Table 1. Laboratory findings.

Survivors (n = 133) Non-survivors (n = 47) Normal range P-value
Age, mean (IQR), years 54 (45 – 67) 71 (60 – 82)
Male 77 30
Female 56 17
Duration of symptoms, days 3.11 (1 – 5) 5.72 (2 – 7)
White blood cells, median (IQR), ×109/L 7.4 (4.8 – 8.8) 9.2 (6.3 – 11.2) 4 – 11 0.001
Hemoglobin count, median (IQR), g/dL 12.7 (11.6 – 13.9) 9.2 (9.8 – 12.5) Males: 13 – 18 0.001
Females: 11.5 – 16.5
Lymphocyte count, median (IQR), ×109/L 1.17 (0.8 – 1.4) 0.75 (0.4 – 1) 1.5 – 4.5 0.001
Neutrophil count, median (IQR), ×109/L 5.5 (3 – 6.5) 7.94 (4.7 – 10.1) 2.0 – 7.5 0.003
Platelet count, median (IQR), ×109/L 230 (151 – 274) 236 (175 – 256) 150 – 450 >0.5
C-reactive protein, median (IQR), mg/L 85 (23 – 108) 122 (111 – 233) <8.0 mg/L 0.004
Ferritin, median (IQR), μg/L 330 (94 – 339) 812 (218 – 1,043) Females: 10 – 200 µg/L; 0.001
Males: 30 – 300 µg/L
Lactate dehydrogenase, median (IQR), units/L 333 (222 – 369) 528 (368 – 640) 110 – 210 0.001
Creatinine, mg/dL 0.9 (0.7 – 1.0) 1.3 (0.7 – 1.7) <1.2 0.004
ALT, U/L 31 (22 – 39) 33 (17 – 35) <24 >0.5
Na, mEq/L 135 (133 – 139) 136 (133 – 140) 135 – 145 >0.5
D-Dimer, median (IQR), ng/mL 830 (430 – 1,210) 2,897 (1,070 – 3,185) <500 0.0003

P-values were calculated using Pearson's chi-square test.

IQR, interquartile range; ALT, alanine aminotransferase.